Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (5,929,267)	$ (5,906,739)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Depreciation	28,155	6,277
Amortization	31,150	28,004
Amortization of ROU Asset		13,517
Amortization of Capitalized Share-Based Payments	132,353	3,531,763
Share-Based Compensation under Equity Incentive Plan	212,030	15,246
Change in Fair Value of Derivative Liabilities	156,445	(1,683,034)
Write-offs of Capitalized Patents		11,300
Change in Inventory Reserve	244,682
Changes in Operating Assets and Liabilities:
Accounts Receivable	(187,288)	(92,490)
Prepaid and Other Assets	10,373	(99,756)
Inventory	(328,922)	14,133
Accounts Payable and Accrued Liabilities	455,378	171,411
Accrued Interest, net	18,345	(5,853)
Reduction of Lease Liability		(13,650)
Net Cash Used in Operating Activities	(5,156,566)	(4,009,871)
CASH FLOWS FROM INVESTING ACTIVITIES
Capitalization of Patents	(20,868)	(49,869)
Purchases of Fixed Assets	(60,000)	(103,773)
Acquisition of Intangibles	(1,785)	(25,374)
Purchase of Short-Term Investments		(1,708,000)
Maturities of Short-Term Investments	1,708,000
Net Cash Provided by (Used in) Investing Activities	1,625,347	(1,887,016)
CASH FLOWS FROM FINANCING ACTIVITIES
Net Proceeds from January 2024 Offering		1,898,296
Net Proceeds from January 2025 Offering	804,346
Net Proceeds from February 2025 Offering	908,627
Net Proceeds from July 2025 Offering	4,281,300
Shares Withheld for Net Share Settlement of Performance Bonuses	(18,000)
Net proceeds from ATM Offering		1,729,810
Net proceeds from Private Placement		3,414,502
Proceeds from Exercise of Pre-Funded Warrants	2,804	9,990
Net Cash Provided by Financing Activities	5,979,077	7,052,598
Effect of Exchange Rate Changes on Cash	8,568	2,492
Change in Cash and Cash Equivalents	2,456,426	1,158,203
Cash and Cash Equivalents—Beginning of Period	1,659,353	2,142,485
Cash and Cash Equivalents—End of Period	4,115,779	3,300,688
NONCASH INVESTING/FINANCING ACTIVITIES
Fair Value of Warrants Issued to Underwriters		71,364
Purchases of Fixed Assets included in Accounts Payable	46,099
Conversion Of Series A Preferred Stock Into Common Stock		290,601
Capitalized Patent Costs included in Accounts Payable	3,796
Gross Shares Issued for Annual Performance Bonuses	$ 121,544